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Abstract
Toll-like receptors (TLRs) are pattern recognition receptors that recognize pathogens based on distinct molecular signatures.
The human (h)TLR1, 2, 6 and 10 belong to the hTLR1 subfamilies, which are localized in the extracellular regions and activated
in response to diverse ligand molecules. Due to the unavailability of the hTLR10 crystal structure, the understanding of its
homo and heterodimerization with hTLR2 and hTLR1 and the ligand responsible for its activation is limited. To improve our
understanding of the TLR10 receptor-ligand interaction, we used homology modeling to construct a three dimensional (3D)
structureof hTLR10andrefined the modelthrough molecular dynamics(MD)simulations.Weutilized the optimizedstructures
for the molecular docking in order to identify the potential site of interactions between the homo and heterodimer (hTLR10/2
and hTLR10/1). The docked complexes were then used for interaction with ligands (Pam3CSK4 and PamCysPamSK4) using
MOE-Dock and ASEDock. Our docking studies have shown the binding orientations of hTLR10 heterodimer to be similar with
other TLR2 family members. However, the binding orientation of hTLR10 homodimer is different from the heterodimer due to
the presence of negative charged surfaces at the LRR11-14, thereby providing a specific cavity for ligand binding. Moreover,
the multiple protein-ligand docking approach revealed that Pam3CSK4 might be the ligand for the hTLR10/2 complex and
PamCysPamSK4, a di-acylated peptide, might activate hTLR10/1 hetero and hTLR10 homodimer. Therefore, the current
modeled complexes can be a useful tool for further experimental studies on TLR biology.
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Introduction
Toll-like receptors (TLRs) are evolutionarily conserved mem-
brane-bound pattern recognition receptors (PRRs) that recognize
a broad spectrum of microbial components such as lipopeptides
and non-self nucleic acids [1]. TLRs play a central role in innate
immunity and are required for the development of adaptive
immune responses. TLRs are type I transmembrane glycoproteins
that consist of an extracellular domain/ectodomain (ECD), a
single transmembrane spanning segment and a globular cytoplas-
mic Toll/interleukin (IL)-1 receptor (TIR) domain [2,3]. The
ECDs encompass 19–25 tandem copies of a motif known as the
leucine-rich repeat (LRR), whose primary function appears to be
ligand recognition and the formation of protein-protein interac-
tions with its partners [4,5,6]. The cytoplasmic TIR domain
recruits the adaptor protein that is essential for the downstream
signaling. To date, 10 hTLRs (human TLRs) and 12 mTLRs
(mouse TLRs) have been identified, each of which responds to
specific microbial products [2,7,8]. TLRs are categorized into six
major families: TLR1, TLR3, TLR4, TLR5, TLR7 and TLR11.
The classification is mainly based on amino acid similarities and
the ligand properties [9]. The present study mainly focused on the
TLR1 family, which includes TLR1, TLR2, TLR6 and TLR10.
Although TLR10 has been identified in humans and its
equivalent homologs can be found in other mammals, it is absent
from mice due to a retrovirus insertion. TLR10 is predominantly
expressed in immune cell-rich tissues, such as the small intestine,
stomach, thymus, peripheral blood lymphocytes, lymphnodes and
tonsils [10,11]. Co-immunoprecipitation studies have shown the
self association of TLR10, as well as TLR1 and TLR2 via the
extracellular domain of these receptors, which plays a pivotal role
in inducing type I interferon in plasmacytoid dendritic cells (PDC)
[12]. The ligand specificity has been elucidated for most of the
TLRs. Specifically, TLR2 and TLR4 recognize Gram-positive
and Gram-negative bacterial cell wall products, respectively, while
TLR5 recognizes a structural epitope of bacterial flagellin and
TLR3, 7, 8 and 9 have been demonstrated to recognize different
forms of microbial-derived nucleic acids [2,13]. However, the
ligand specificity of TLR10 remains elusive. The present study was
conducted to identify the hTLR10 self dimerization region as well
as its partners and possible ligands to activate these complexes.
Computational modeling has become an essential tool in
guiding and enabling rational decisions with respect to hypothesis
driven biological research. In the absence of an experimentally
determined structure, homology modeling could provide a rational
opportunity to obtain a reasonable 3D structure. The goal of
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coordinates of a query protein based on the known structure of
a sequence homology (template). The 3D structure of a protein
provides important information for understanding its biochemical
function and interaction properties in molecular detail. Here, we
used a combination of homology modeling and MD simulation to
construct a detailed 3D model of hTLR10. This model was then
used to investigate the nature of the three different binding modes
with hTLR1 and hTLR2, which provided the complex formation
of the hTLR10/1, hTLR10/2 hetero and hTLR10 homodimer.
These complex structures were then studied to analyze the
intermolecular contacts and to identify the specific residual level of
interactions between the two proteins. The results presented in this
study demonstrated that the binding orientations are similar
among all TLRs; however, the residual interactions with their
partners are specific. The hTLR10 complexes were then used for
protein-ligand docking to identify the potential ligands that
activate the TLR10 signaling. Finally, we have provided possible
ligands for the hTLR10 complex activation.
Methods
Homology modeling
The primary sequence of hTLR10 (accession number:
AAQ88667) and crystal structure coordinates of hTLR1 (PDB
ID: 2Z7X-B) were loaded into the Molecular Operating
Environment (MOE). The primary structure of hTLR1 and
hTLR10 were aligned and carefully checked to avoid deletions or
insertions in each LRR and then corrected manually based on the
LRR motif identified by TollML [14,15]. A series of 10 hTLR10
models were independently constructed with MOE by using the
Boltzmann-weighted randomized procedure. There was no
difference in the number and organization of secondary structural
elements and no significant main chain deviation among the 10
models developed. However, the model with the highest packing
score was selected for full energy minimization (MOE packing
score is 22.5478). The selected final model was subjected to MD
simulation for structural refinement [16]. The glycosylation sites
present in the final model were predicted by using the NetOglyc
server [17].
Molecular dynamics simulation
The MD simulations were conducted using the GROMACS
3.3.3 software [18]. The individual structures of the modeled
hTLR10, 1 and 2 were placed into a cubic box maintaining 10 A ˚
between the box edges and the protein surface. The resulting
system was then solvated with the simple point charge (SPC) water
molecule and then minimized by using steepest descent method
with GROMOS96 43a1 force field. Periodic boundary conditions
were applied in all directions and the system was neutralized by
adding appropriate counter ions (Na
+ or Cl
2). A twin range cutoff
was used for long-range interaction: 9 A ˚ for van der Waals
interactions and 14 A ˚ for electrostatic interactions. All bond
lengths were constrained with the LINCS algorithm [19]. The
SETTLE algorithm was applied to constrain the geometry of
water molecules [20]. The energy minimized system was subjected
to 100 ps equilibration and subsequently used in the 2 ns
production with a time step of 1 femtosecond (fs) at constant
temperature (300 K), pressure (1 atm) and number of particles,
without any position restraints. In each case, the final conforma-
tion obtained at the end of the simulation was further refined by
energy minimization for molecular docking. The refined model
was validated using the PROCHECK program [21] and the
Verify 3-dimensional (3D) server [22,23].
Molecular docking
The three widely accepted rigid-body protein-protein docking
programs, GRAMM-X [24], ZDOCK [25] and RosettaDock [26]
were used to predict and assess the interactions between hTLR10/
1, hTLR10/2 and hTLR10 homodimer complexes. Each docking
method returned the 100 most probable predictions out of
thousands of candidates based on geometry, hydrophobicity and
electrostatic complementarity of the molecular surface. We thus
performed restrained pairwise docking for hTLR10 heterodimer
complex based on the comparative studies results. Our compar-
ative studies clearly indicated that C-terminal region of LRR11–
14 plays a crucial role in dimerization. When we used our
comparative studies results as a constraint for homodimer, we
obtained the complex similar to heterodimer. However, the active
site was positioned far away from the ligand binding region and
hence, it was not appropriate to conduct further studies.
Consequently, the residues located near the hTLR10 active site
were considered as a constraint in our docking studies. The buried
surface interaction area of dimer models were calculated using the
PROTORP server (protein-protein interface analysis) [27].
Electrostatic potential calculation
The electrostatic potential surface of the hTLR10, 2 and 1 were
calculated using the PyMOL APBS (http://apbs.sourceforge.net)
tools. The molecular surfaces and ribbons of the figures were built
and colored with the PyMOL visualizing tool [28].
Computational alanine scanning to predict the binding
energy Hot-spots in the complex interface
The hTLR10/1, hTLR10/2 hetero and hTLR10 homodimer
were submitted to the Robetta Alanine scanning server (http://
robetta.bakerlab.org/alascansubmit.jsp) to predict the energetical-
ly important amino acid residues in its interface. The alanine
scanning server calculates the effects of alanine mutations on the
binding free energy of a protein-protein complex by using a simple
free energy function. The program replaces each of the interface
residues with alanine residue and computes the effect of this
mutation on the binding free energy of the complex. This analysis
serves as the identification of important residues that are crucial
for hTLR10 homo and heterodimer formation.
Construction and geometry optimization of hTLR10
ligands
Two ligands, Pam3CSK4 and PamCysPamSK4, have been
predicted to activate the hTLR10 complexes. The crystal structure
of hTLR1/2/Pam3CSK4 complex is known, and we took the
Pam3CSK4 site for docking. In case of PamCysPamSK4,w e
modified the Pam3CSK4 at C2 position. Partial charges were
added to protonated and unprotonated molecules using the Merck
Molecular Force Field 94X (MMF94X), which is suitable for small
molecules [29]. All structures were energy minimized using the
conjugated gradient/truncated Newton optimization algorithm
with a convergence criterion of 0.05 kcal/mol, e=1.
Binding site selection and exploration
The Site Finder module of MOE 2008.10 was used to identify
the possible substrate binding pockets within the newly generated
3D structure of the hTLR10/1, hTLR10/2 hetero and hTLR10
homodimers. Hydrophobic or hydrophilic alpha spheres served as
probes denoting zones of tight atom packing. The alpha spheres
were used as centroids for the creation of dummy atoms to define
the potential sites throughout the docking process.
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Protein-ligand docking was conducted using MOE-Dock
2008.10 and ASEDock. The docking procedure has been
previously described [30], and the same procedure was followed
for hTLR10 complexes and its ligands.
Validation of the hTLR10 ligand docking process via
hTLR1/2/Pam3CSK4 docking
Two docking methods, MOE-Dock 2008.10 and ASEDock, were
used to assess the validity of the hTLR10 complex-ligand docking
predictions by calculating possible bound conformations of hTLR1/
2/Pam3CSK4complexes. The crystal structure of hTLR1/2 was
retrieved from the PDB and prepared for docking, and partial
charges and hydrogen atoms were added. The obtained docking
poses (hTLR1/2/Pam3CSK4) were then compared with the original
crystal structure.
Results and Discussion
Molecular model of hTLR10 and evaluation
We built the 3D structure of hTLR10 using the crystal structure
of hTLR1, which serves as a suitable template (PDB ID 2Z7X-B)
[31]. Generally, TLR ectodomains are composed of a repeated
number of LRR, which vary in numbers among the known TLRs
[32]. Recent modeling studies of endosomal TLRs (hTLR7, 8, 9)
have shown that researchers used multiple templates to derive an
optimum alignment for all endosomal LRRs [33]. Conversely, we
used a single template (2Z7X-B) because it has 19 LRR, which are
aligned well with the 19 LRR in the target hTLR10. The primary
sequence alignment of hTLR10 and its template was used to
construct the final model (Figure 1). The identity and similarity
between the target and template were 40.74% and 59.26%,
respectively. Additionally, the sequence identity of each LRR
between the target/template is listed in Table 1. Direct
comparison of the modeled hTLR10 with its template showed
that the structural differences observed in the loop regions of the
LRR6, LRR14, LRR15, LRR19 and the rest of the regions were
similar to that of the template with RMSD values of 1.14 A ˚. These
structural differences occur away from the ligand binding sites
(Figure S1). Moreover, when we compared hTLR10 with the
available crystal structure of hTLR2 (in the same family) [31], we
found that the variation in loop regions in LRR1, LRR2, LRR3,
LRR4, LRR5, LRR7, LRR8, LRR11, and the rest of the regions
was similar to that of hTLR2 with RMSD values of 1.54 A ˚. The
final 3D structure of hTLR10 showed large characteristic
‘‘horseshoe-like’’ structures with concave surfaces formed by 19
parallel b-strands, whereas the convex surface contains more
diverse secondary structural elements, including a variety of
different length loops, 11 a helices and three 310 helices. Like all
TLRs, hTLR10 also contains the N-linked glycosylation consensus
sites. The glycans were exemplified to be non-functional for ligand
binding [25,28–31]. Hence, we predicted seven glycosylation sites
for hTLR10, which are located in the LRR4 (Asn91), LRR6
(Asn142), LRR8 (Asn189), LRR10 (Asn231), LRR12 (Asn254),
LRR15 (Asn369) and LRR16 (Asn378). However, our prediction
also revealed that none of the glycosylation sites contributed in the
dimerization and ligand binding sites. The predicted glycosylation
sites are similar to those of TLR1 family members [34].
Structure refinement and stability evaluation by
molecular dynamics
We performed 2 ns MD simulations to explore the structural
stability of the model structure of hTLR10 along with the crystal
coordinates of hTLR2 and 1. The crystal structures of the hTLR2/1
heterodimer along with its ligand were solved at 1.8 A ˚ resolutions
[31]. The ligand was removed from the heterodimer and the dimer
was separated into hTLR1 and hTLR2. To evaluate the overall
stability of these models, we calculated the RMSD from the initial
structure of all backbone Ca atoms as a function of simulation time,
as shown in Figure 2A. The hTLR1 and hTLR2 reached equilibrium
around 500 ps, whereas hTLR10 reached the plateau after 900 ps.
The RMSD value of the Ca atom between the initial snapshot and
the final structure was around 2.8 A ˚ for hTLR10, 2.6 A ˚ for hTLR2
and 2.4 A ˚ for hTLR1, which suggests that the protein remains stable
after reaching the equilibrium. The final snapshot at the end of the
simulation was selected from the 2 ns and subjected to further energy
minimization for fine refinement. The optimized structures of the
hTLR10, hTLR2 and hTLR1 were validated using the PRO-
CHECK program and Verify 3D server. Analysis of hTLR10
revealed that 94% of the dihedral angles are found in most favorable
regions of the Ramachandran plot and that the remaining 6% are
found within the allowed regions (Figure S2). This highlights the
excellent geometry of the model. Verify3D reports no values below
0.09, further indicating that all the residues are located in favorable
structural environments (Figure 2B). It should be noted that before
the simulation, hTLR1 and 2 had a few residues in the outlier region.
However, evaluation of the optimized structure of hTLR1 from the
MD simulation revealed that 96.1% of the residues were present in
the mostfavorableregions and remaining 3.9% residues were located
in allowed regions (Figure S2). Verify3D reported no values below
0.15 (Figure 2B). In the case of hTLR2, 94.14% of the residues were
located in most favorable region and 5.85% residues were located in
the allowed region (Figure S2). Verify3D reported no values below
0.17 (Figure 2B). This analysis indicates excellent geometry of the
crystal structure after the MD simulation and is thus considered a
reliable source for further studies.
Comparison of hTLR10 with hTLR1 and hTLR2
As shown in Figure 3, the structure based sequence alignment of
hTLR10 with hTLR2 and 1 shows that the LRR consensus
sequence motif ‘‘LxxLxLxxNxLxxLxxxxLxxLxx’’ aligned well at
the N-terminal, C-terminal and Central domain. In the above
sequence motif, x denotes any amino acids, and L represents
leucine, which can be replaced by other hydrophobic amino acids
such as isoleucine, valine and phenylalanine. The consensus
asparagine (N) in the LRR motif plays an important role in the
formation of the hydrogen bonds with the carbonyl backbone of
the neighboring strands [5,35]. The hTLR10 N-terminal domain
was composed of 1–4 LRR modules, with each LRR module
length being around 24 residues and the structurally important
asparagine ladder being conserved. Conversely, the central
domain is composed of 5–11 LRR modules and differs
considerably from the standard structure, with the lengths of their
LRR modules ranging from 20–30 amino acids and their b-sheet
conformations deviating significantly from those of the standard
LRRs. The absence of an asparagine ladder in the central domain
leads to the formation of an unusual b-sheet conformation.
However, we observed such unusual regions in hTLR1 and 2.
These unusual regions of hTLR1 and 2 possess hydrophobic
pockets, which have been reported to play an essential role in
ligand recognition [31]. This analysis shows that residues situated
in the ligand binding hydrophobic pockets in hTLR2 and 1 are
conserved in hTLR10 (Figure 3 shaded by cyan). Hence, we
believe that this region in hTLR10 might play a role in ligand
recognition. Finally, the C-terminal domain of hTLR10 contains
12–19 LRR modules and the asparagine ladder is conserved in all
LRRs, with each LRR module ranging in length from 20–30
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occur at the position of LRR12 in hTLR2, LRR4 in hTLR10, and
LRR12 in hTLR1 [32]. However, our structure based analysis of
hTLR10 along with the crystal structures of hTLR1 and hTLR2
did not reveal such an insertion in these three receptors.
Receptor dimerization interface
The signaling mechanism of all TLRs is likely involved in
dimerization of the ectodomains [36]. However, this can be
achieved in various ways by using different receptors and
stimulation. It should be noted that the ligand induced
Figure 1. Sequence alignment used to build hTLR10, based on the hTLR1 template retrieved by MOE. Gray blocks: level of sequence
similarity. Tallest blocks: identical residues at that position. Intermediate blocks: non-identical residues that are relatively conservative with respect to
their properties. Small blocks: residues sharing mild conservation with respect to structure or function. The absence of a block indicates no
appreciable structure/function conservation. Gaps in one sequence relative to the other are indicated by dashes. 2Z7X-B denotes hTLR1. The
nineteen LRR are highlighted and contrasted by varying the colors.
doi:10.1371/journal.pone.0012713.g001
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structures have already been solved based on this idea [31,37,38].
However, this cannot be conducted computationally; hence, we
initially focused on the dimerization mechanism of hTLR10 with
hTLR2 and 1 using protein-protein docking. The procedure of
protein-protein docking is highly computationally oriented. The
reliability of docking results strongly depends on the quality of the
docking methods. To verify the prediction confidence of the TLR-
TLR interaction of these three methods, GRAMM-X, ZDOCK
and RosettaDock, we restrainedly inputted hTLR1 and hTLR2,
for which the heterodimeric crystal structure is known, as test cases
[31]. The native dimerization structure of hTLR2/1 was found in
the top 100 solutions and it was ranked 23rd by GRAMM-X, 1st
by RosettaDock and 80th by Z-DOCK. These results demonstrate
that our docking protocol was reliable; therefore, we used it in the
subsequent hTLR10/2, hTLR10/1 hetero and hTLR10 homo-
dimer docking calculations.
We conducted restrained rigid-body docking of the hTLR10
homo and heterodimer. Each docking returned the 100 most
probable models from unbound monomer components. Thus,
each complex received a total of 300 candidate models
separated into three sets. Some models from the same set had
similar conformations, whereas most differed considerably from
one another. There were some shared models (intersection)
across both sets for each complex. These shared models were
considered as more confident solutions than others. The
optimal docking solution was selected for each complex from
the 300 candidates based on the following criteria: (i) models
that do not exist in the intersection of the three resulting sets
were excluded; (ii) only those models in which the dimerization
geometry was supported by the results obtained from our
comparative studies were included. The comparative studies
clearly indicated that the dimerization region is located at the
border of the central region followed by the C-terminal end
(Figure 3 represented in green color shade). Additionally, we
considered the active site region to be located on the adjacent
sides in the dimer interface. This two-step filtering led to a
unique solution. The ZDOCK/GRAMM-X/RosettaDock
ranking and the buried surface interaction area of all optimal
models are provided in Table 2.
hTLR10-hTLR2 complex
The orientation and interaction of the final hTLR10/2 docked
complex was similar to the hTLR2/1 crystal complex and
TLR10/1 (Figure 4A&B). The buried surface at the interface of
the hTLR10/2 complex constitutes 945.58 A ˚ 2 from the hTLR10
and 958.39 A ˚ 2 from hTLR2, which is in the range of typical
physiological interaction surfaces. Based on the solvation energy
calculated from the buried surface area and specific electrostatic
interaction, the dimer interface was judged by PROTORP server.
There are 14 residues from the hTLR10 that make contact
(DASA.1A ˚ 2) with 15 residues from hTLR2. The non-covalent
interactions across the hTLR10/2 interface are listed in Figure 4C.
The hTLR10/2 interface possesses a small hydrophobic core
located in the central region (LRR11) surrounded by hydrogen
bonding and ionic interaction in the periphery. Five hydrogen
bonds are present in the interface of the hTLR10/2 complex
(Figure 4D), which includes a double hydrogen bond between the
K347
0 side chain and the OH group of T361
9. The carbonyl
backbone of N397
0, carboxylic group of E375
0 and carboxamide
group of N345
0 form a hydrogen bond with the NH2 group of
K383
9, NH2 group of Q337
9 and carboxylic group of E385
9,
respectively. Single apostrophes are used for the hTLR10 residues
and double apostrophes for the hTLR2 to differentiate them from
the ligand throughout the article.
Table 1. Sequence identities (%) of target-template of each
LRR pairs.
LRRs hTLR10 LRRs hTLR10
1 45.83 11 24.14
2 62.5 12 40.91
3 38.1 13 41.67
46 8 1 43 6
5 47.83 15 37.5
6 26.09 16 45.45
7 41.67 17 43.48
8 23.33 18 36.36
9 44.44 19 20.83
10 50 Avg 40.74
Note: LRRs, Leucine rich repeats; hTLR10, human Toll like receptor10; Avg,
average value.
doi:10.1371/journal.pone.0012713.t001
Figure 2. Structure refinement and stability evaluation. (A) The MD trajectory-based analyses for the model refinement. The RMSD plot of
hTLR10, 2 and 1 during the dynamic simulation. (B) The 3D structure profile plot for hTLR10, 2 and 1. The refined hTLR1 and hTLR10 are shown in blue
and red, whereas hTLR2 is shown in green.
doi:10.1371/journal.pone.0012713.g002
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PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12713Figure 3. Structure-based sequence alignments of hTLR10, 2 and 1. The hTLR10, 2 and 1 sequences are aligned based on their structures.
Conserved leucines and asparagine ladder are written in red and green, respectively. The positions of b-strands are shown above the consensus
patterns.
doi:10.1371/journal.pone.0012713.g003
Table 2. Ranking and interaction area of the selected docking models.
Complexes GRAMM-X Z-DOCK RosettaDock Interaction Area (A ˚2)
hTLR10/hTLR2 33 26 1 945.58
hTLR10/hTLR1 45 73 8 809.63
hTLR10/hTLR10 81 59 13 858.74
doi:10.1371/journal.pone.0012713.t002
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The buried interface surface area between the hTLR10 and the
hTLR1 is 809.63 A ˚ 2 from hTLR10 and 798.12 A ˚ 2 from hTLR1
(Figure 5A&B). There are 15 residues from hTLR10 that makes
contact (DASA.1A ˚ 2) with 10 residues from hTLR1. The non-
covalent interactions such as hydrophobic and ionic interactions
across the hTLR10 and the hTLR1 are listed in Figure 5C. Five
hydrogen bonds are present in the interface of the hTLR10/1
complex (Figure 5D). The NH2 group of R337
+ forms two hydrogen
bonds with carboxylic group of E385
9 and E363
9, respectively. The
carboxamide group of Q383
+ forms a hydrogen bond with the
carboxylicgroupofE385
9of hTLR10. The side chain of K383
9forms
two hydrogen bonds with the backbone oxygen group of L359
+ and
the backbone oxygen group of N357
+. Single apostrophes are used
for the hTLR10 residues and double apostrophes for the hTLR2 to
differentiate them from the ligand throughout the article.
hTLR10-hTLR10 dimer
The hTLR10 homodimer docking orientation is the same, but the
dimerization region is different from the hTLR10 heterodimer
complexes.ThehTLR10homodimerizationregionincludesLRR11-
17 in comparison to LRR11-14 in the heterodimer complex. Such
types of dimerization have been conspicuously noted in TLR4
homodimer. The hTLR10 homodimer docked complex resembles a
typical ‘m’ shaped heterodimer, with two N-termini extending
outwards in opposite directions and LRRCT modules converging at
the center (Figure 6A&B). However, the hTLR10 homodimer
possesses more hydrophobic and hydrogen bond interactions than its
heterodimer complex. The buried surface area across the hTLR10
homodimer complexis 858.74 A ˚ 2.Thereare13and 14residues from
hTLR10 chain D and E
* that contribute to the above interface.
Figure 6C shows the hydrophobic and ionic interaction between the
homodimer of hTLR10/10
*. Eight hydrogen bonds are present at
the interface of the hTLR10 homodimer, which includes the
carbonyl backbone of N407
9 and Y430
9 that forms two hydrogen
b o n d sw i t ht h es i d ec h a i no fK 4 3 2
*.S i m i l a r l y ,t h es i d ec h a i n so f
K432
9, Q454
9,N 3 6 2
9 and K383
9 form hydrogen bonds with the side
chains of N404
*,N 4 2 5
*,K 3 5 6
* and E358
*, respectively. The
backbone oxygen group of K409
9 forms hydrogen bonds with the
side chain of Y403
* (Figure 6D). Single apostrophes are used for the
hTLR10 residues and asterisks for the other hTLR10 monomer to
differentiate them from the ligand throughout the article.
Figure 4. Protein-protein docking model of the hTLR10/2 complex. hTLR2 and hTLR10 are shown schematically in cyan and red, respectively.
Each LRR module is numbered and the N-terminal, central, and C-terminal subdomains are labeled. A and B, side view (A) and top view (B) of the
complex in ribbon representation. (C) Residues involved in the heterodimer interface in the hTLR10/2 are shown in cyan and red, respectively. The
interactions between the residues are depicted by dashed lines. (D) Hydrogen bonds between hTLR10 and hTLR2 (cyan) are marked by black dashes.
doi:10.1371/journal.pone.0012713.g004
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interface of the hTLR10 homo and heterodimer vary depending on
their partners, which clearly demonstrates that hTLR10 binds
specifically with its partners. The predicted docked complexes were
cross checked by the electrostatic potential of the individual structure.
The surface electrostatic calculation from hTLR10 revealed that the
highly negative charged surface along with a few positive patches were
located at the central region, followed by the C-terminal (LRR11-14)
(represented by the green color in Figure 3), whereas hTLR2 and 1
contain highly basic amino acids (Figure 2B). The hTLR10 negatively
charged surface (LRR11-14) would bind with hTLR2 and 1 (LRR11-
14) based on their respective opposite charges. However, in the case of
hTLR10, homodimer formation occurs between LRR11-17 of each
monomer. These LRR regions of each monomer have eight negative
and four positive charges where only a few residues are involved in the
complementary interaction has shown in Figure S3.
Virtual Ala scanning
An approximate estimation of the individual contributions of the
amino acid residues involved in the interaction was obtained by
computational methods. We used the Rosetta interface computa-
tional mutagenesis approach [39], which is similar in principle to
the experimental Ala-scanning mutagenesis procedure, to estimate
the change in the binding free energy (DDGbind) when each residue
at the interface of the hTLR10/2, hTLR10/1 and hTLR10/10*
complex is mutated to Ala. We utilized a cut-off of DDGbind.1.0
kcal/mol to qualitatively identify hot-spot residues that are essential
for the interactions. Correctly identified essential residues have
predicted and observed (DDGbind) values greater than or equal to
1 kcal/mol; whereas correctly identified neutral residues have
predicted and observed (DDGbind) values less than 1 kcal/mol.
To verify the prediction confidence of alanine-scanning muta-
genesis, we input the hTLR2/1 crystal structure as a test case. The
program predicted a few residues across the complex interface. Of
those, P315 in TLR1 has a value of 2.65. A mutation in this residue
leads to loss of the hTLR1/2 signaling [40]. This shows that P315 is
essential for the dimerization of hTLR1/2 complex. Therefore, we
believe that our protocol is reliable and we subsequently used it to
evaluate the docked complexes. The alanine scanning experiments
showed that two residues (T361
9 and K383
9) from hTLR10 and two
Figure 5. Docking model of the hTLR10/1 complex. The hTLR10 and hTLR1 are shown schematically in red and light blue, respectively. Each
LRR module is numbered and the N-terminal, central, and C-terminal subdomains are labeled. A and B, side view (A) and top view (B) of the complex
in ribbon representation. (C) Residues involved in the heterodimer interface in hTLR10/1 are shown in red and blue, respectively. The interactions
between the residues are depicted by dashed lines. (D) hTLR10 residues interact with hTLR1 by making hydrogen bonds (black dashes).
doi:10.1371/journal.pone.0012713.g005
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0 and Y376
0) from hTLR2 were crucial for the
formation of hTLR10/2 complex (Table 3), emphasizing their
contribution to the complex stability. Conversely, evaluation of the
hTLR10/1 complex revealed that two residues from hTLR10
(K383
9 and E385
9) and two residues from hTLR1 (R337
+ and
Q383
+) were indispensible for hTLR10/1 complex formation.
Finally, the dimer complex showed that one residue from hTLR10
(K383
9) and one residue from hTLR10
* (K356
*) were essential for
homodimer complex formation. The rest of the residues at both
complex interfaces had DDGbind values .0.1 kcal/mol, which
suggests that their mutation to Ala does not have any functional
consequences on the formation of complexes.
Possible ligand recognition for hTLR10 based on the
cavity volume
Recent studies have revealed the binding of the tri-acylated
(Pam3CSK4) and di-acylated lipopeptide (Pam2CSK4) to hTLR2/
1 and mTLR2/6 complex, respectively [31,41]. It has also been
Figure 6. Docking model of the hTLR10/10* complex. hTLR10 and hTLR10* are shown schematically in red and green, respectively.
PamCysPamSK4 is shown in dark blue. Each LRR module is numbered and the N-terminal, central, and C-terminal subdomains are labeled. A and B,
side view (A) and top view (B) of the complex in ribbon representation. (C) Residues involved in the homodimer interface in the hTLR10/10* are
shown in red and green, respectively. The interactions between the residues are depicted by dashed lines. (D) hTLR10 residues interact with hTLR10
by making hydrogen bonds (black dashes).
doi:10.1371/journal.pone.0012713.g006
Table 3. Results of the predicted contributions of residues
through virtual alanine scanning.
TLR10/2 TLR10/1 TLR10/10*
PDB Chain DDGbind PDB Chain DDGbind PDB Chain DDGbind
Y323 A 2.04 Q383 B 1.25 K383 E 1.35
K347 A 2.72 R337 B 1.70 T430 E 3.56
Y376 A 0.92 K383 D 1.04 K383 D 1.32
T361 D 1.23 E385 D 1.01 K432 D 2.68
K383 D 0.93
Note: Chain A, hTLR2; Chain B, hTLR1; Chain D, hTLR10; Chain E, hTLR10*; PDB,
position of mutated residues in the pdb file; DDGbind, predicted change in
binding free energy upon alanine mutation.
doi:10.1371/journal.pone.0012713.t003
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pocket with a volume of ,1200 A ˚ 3 and that hTLR1 has a single
acylated lipid binding pocket with a volume of 400 A ˚ 3. However,
the cavity volume of our hTLR10 model was 508 A ˚ 3. This pocket
size diversity is mandatory for discrimination of structurally
analogous lipopeptides. Unlike other LRR proteins, the ligand
binding cavity is located in the convex region, which lies in
between LRR9,12 [31]. The domain-exchange experiments
showed the importance of these regions (LRR9-12) in TLR1 and
6, which plays a crucial role in discrimination of a wide variety of
ligands.
In addition to the cavity volume, we compared the hydrophobic
amino acids lining the lipid binding pocket of hTLR10
(LRR9,12) with the template hTLR1 (LRR9,12). The results
showed that out of 18 hydrophobic residues, nine were identical
and the rest were replaced by other hydrophobic residues in
hTLR10 (Figure 7C). Previous studies have shown the importance
of M338 and L360 in TLR1, which play a crucial role in ligand
recognition. Substitution of these residues in TLR1 by F343 and
F365 in TLR6 results in blocking the ligand binding cavity due to
the bulky side chain. However, these important residues are
identical in hTLR10 (M338 and L360) and could play a significant
role in recognizing a single acyl chain of lipopeptide (Figure 7D).
The results of the present study clearly demonstrate that
hTLR10 might be able to accommodate single acyl chains from a
tri or di-lipopeptide ligands. This provides some information that
may enable identification of the ligand responsible for the
activation of the hTLR10/2, hTLR10/1, and hTLR10/10
complexes. Previous studies have shown that hTLR2 can
accommodate two ester bound lipid chains [31] and hTLR10
was found to possess amide bound lipid binding chains in the
current study, which indicates that the tri-acylated (Pam3CSK4)
lipopeptides act as ligand molecules. Additionally, the hTLR10
and hTLR1 central domain (LRR9-12) each possess a single acyl
binding cavity, which indicates that neither Pam2CSK4, PamCy-
sPamSK4 nor Macrophage-activating lipopeptide-2 (MALP-2) are
responsible for the activation of hTLR10 homo and hTLR10/1
heterodimer complexes. So, we ruled out the possibility of the
Pam2CSK4 and MALP-2 due to its nature. These ligands possess
two ester bound lipid chains that run parallel to each other and it
is not possible to accommodate both hTLR10 homo and
hTLR10/1 heterodimer complexes due to the lack of a binding
cavity. Whereas, the PamCysPamSK4 structure is different from
the above di-acyl peptides, which have acyl chains located at the
C1 and C3 atoms of glycerol (Figure S4). We have hypothesized
that these two acyl chains can be accommodated by hTLR1 and
hTLR10 respectively. We have tested our hypothesis by the
docking experiments.
Protein-ligand docking validation of known TLR1/2/
Pam3CSK4 complexes
To evaluate our docking simulation, the crystal structure of
hTLR1/2/Pam3CSK4 was downloaded from the PDB and
used to conduct two different docking calculations [31]. The
dominant clusters from the MOE-Dock and ASEDock docking
simulations were found to have the same binding orientation
when compared with the original crystal structure. The
similarity between the present docked poses (ASEDock yielded
bound conformations with the lowest RMSD (0.14), followed
by MOE-Dock (0.38)) and the crystal structures shows that our
docking protocol was able to reproduce the near native
hTLR1/2/Pam3CSK4 complex. Therefore, we consider that
our protocol to be trustworthy and we used it in the subsequent
docking calculations.
Figure 7. Structural comparison of ligand binding sites. (A) Structural comparison of the lipid-binding pockets of hTLR1 (Blue) and hTLR10
[12]. (B) Superimposition of the TLR6 (Green), TLR10 [12] and TLR1 (Blue): The residues responsible for the channel-blocking F343 and F365 in TLR6
are shown as green sticks and the corresponding residues M338
9 and L360
9 of TLR10 and M338
+ and L360
+ of TLR1 that are not involved in blocking
are shown as red and blue sticks, respectively.
doi:10.1371/journal.pone.0012713.g007
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The hypothesized (PamCysPamSK4, Pam3CSK4) ligands were
docked into the active site of hTLR10/1, hTLR10/2 and
hTLR10/10
*. A close up view of the Pam3CSK4 in the
hTLR10/2 binding sites revealed an extensive spatial overlap of
the predicted best poses, despite the variety of docking methods
employed (Figure 8A). The bound conformation of the ligand
present in the hTLR10/2 shows that the two ester-bound lipid
chains of Pam3CSK4 are inserted in hTLR2, through a crevice
formed between the LRR11 and LRR12 loops and interact with its
internal hydrophobic pocket, whereas the remaining amide-bound
lipid chains are inserted into hTLR10 through the gap between the
LRR11 and LRR12 loops and interact with its internal hydropho-
bic pocket. The conserved cysteinyl group and glycerol backbone of
the lipopeptide is located in the narrow opening formed, where the
hTLR10 and hTLR2 pockets join. Their positions are partially
fixed by five hydrogen bonds: between the backbone nitrogen of
F349
99 and a carbonyl oxygen of the lipopeptide, between the
backbone oxygen of N294
99 and the backbone nitrogen of K4 in
the lipopeptide, between the backbone oxygen of Y313
9 and the
backbone nitrogen of K3 in the lipopeptide, between the carboxamide
group of Q316
9 and the amide oxygen in the lipopeptide and between
the Q315
9 side chain and the carbonyl backbone of K5 in the
lipopeptide. The docked complex of hTLR10/1/PamCysPamSK4
shows a slight diverse binding mode in comparison with the TLR2/1/
Pam3CSK4 and mTLR2/6/Pam2CSK4 complex.
It is important to note that the ester bound lipid chain attached
to the glycerol is longer than the amide bound lipid chain. The
cavity volume comparison clearly indicates that hTLR10 (518 A ˚ 3)
is slightly higher than hTLR1 (400 A ˚ 3). Hence, the ester bound
lipid chain cannot accommodate in hTLR1. As expected, the
docking results showed that ester-bound lipid chains are
recognized through the binding pocket of hTLR10 and that
amide-bound chains are recognized through the binding pocket of
hTLR1 (Figure 8B). There are four hydrogen bonds that are
formed in the hTLR10/1 binding pocket: between the carboxylic
group of D288
9 and the NH2 group of K4 in the lipopeptide,
between the hydroxyl group of Y320
9 and the amide oxygen in
the lipopeptide, between the carbonyl backbone of G313
+ and
the backbone nitrogen of K3 in the lipopeptide and between the
carboxamide of Q316
+ and the amide oxygen in the lipopeptide.
Single apostrophes are used for the hTLR10 residues and a plus
symbol for the hTLR1 monomer to differentiate them from the
ligand.
In case of the hTLR10 homodimer, docking with PamCy-
sPamSK4 revealed that there is a slight difference in the
orientation of the ligand recognition site as well as the residual
contribution in the binding pocket. The LRR11 and LRR12 loops
of both hTLR10 chains are located in the center of the
dimerization interface and provide key hydrophobic residues to
enable recognition of the lipid chains of PamCysPamSK4
(Figure 8C). The hydrogen bonds present at the interface of
hTLR10/10
* with PamCysPamSK4 are as follows: between the
carboxylic group of Q316
9 and the amide oxygen in the
lipopeptide, between the backbone oxygen of D288
9 and K4 in
the lipopeptide, between the backbone oxygen of Y313
* and the
backbone nitrogen of K3 in the lipopeptide, between the
carboxamide of Q316
* and the amide oxygen in the lipopeptide
and between the carboxamide of Q315
* and K5 in the
lipopeptide. The docking studies clearly indicate that LRR9-12
present in the TLR1 family members plays a crucial role in ligand
recognition, and that the hydrophobic residues present in that
region are important for recognizing the acyl chain. These results
are in agreement with the domain-swap experiments [31].
Furthermore, the possible ligands predicted in this study are in
agreement with those of a previous study conducted by Hasan et
al., who reported that the ligands for TLR1 family such as tri- and
di-acylated lipopeptides might be the same for hTLR10 [12].
Previous studies have shown that NF-kB, ENA-78 and other gene
promoters are activated by an unknown ligand through the
TLR10 pathway [42]. Based on our current study, PamCy-
sPamSK4 and Pam3CSK4 might be possible ligands for the
activation of TLR10 signaling pathways.
Taken together, we elucidated the 3D structure of hTLR10 to
show its homo and heterodimerization with hTLR1 and hTLR2.
Based on these models, we also suggest three possible receptor
dimerization schemes that require different minimum ligand sizes.
These complexes provided the specific active sites, which enabled
us to predict the possible ligands necessary for the TLR10
activation. We also proposed that PamCysPamSK4 and
Pam3CSK4 are the possible ligand molecules for the TLR10
pathway. Our models provide a structural framework for
interpreting experimental data and allow predictions of the TLR
signal transduction process. The presented modeling approach can
be extended to other repetitive protein domains.
Supporting Information
Figure S1 The backbone superimposition of hTLR10 with
hTLR2 and hTLR1 are shown as red, cyan and blue, respectively.
Found at: doi:10.1371/journal.pone.0012713.s001 (1.75 MB
TIF)
Figure S2 The Ramachandran plot of refined hTLR10, 2 and 1.
Found at: doi:10.1371/journal.pone.0012713.s002 (1.85 MB TIF)
Figure S3 Electrostatic potential on the molecular surface of
hTLR10, 2 and 1. The LRR9-17 patches of hTLR10, 2 and 1 are
circled. Red and blue indicates negative and positive potential,
respectively. The surface potential was calculated and displayed
using the PyMOL ABPS tool.
Found at: doi:10.1371/journal.pone.0012713.s003 (2.64 MB TIF)
Figure S4 Chemical structure of lipopeptides used for docking
studies.
Found at: doi:10.1371/journal.pone.0012713.s004 (0.76 MB TIF)
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Figure 8. Protein-ligand docking complex. (A) The docked lipopeptide-binding site of the hTLR2-hTLR10 complex. The hTLR2 and hTLR10
residues involved in Pam2CSK4 binding are shown in cyan and red, respectively. Potential hydrogen bonds connecting the TLRs and the ligands are
shown in broken black lines. Pam3CSK4 is shown in dark blue. (B) The docked lipopeptide-binding site of the hTLR10-hTLR1 complex. The hTLR10 and
hTLR2 residues involved in PamCysPamSK4 binding are shown in red and light blue, respectively. Potential hydrogen bonds connecting the TLRs and
ligands are indicated by broken black lines. PamCysPamSK4 is shown in dark blue. (C) The docked lipopeptide-binding site of hTLR10-hTLR10*
complex. The hTLR10 and hTLR10* residues involved in PamCysPamSK4 binding are drawn in red cyan green, respectively. Potential hydrogen bonds
connecting the TLRs and the ligands are shown by broken black lines. PamCysPamSK4 is shown in dark blue.
doi:10.1371/journal.pone.0012713.g008
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